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OBJECTIVE—The objective of the study was to prospectively
assess the association between lactation duration and incidence
of the metabolic syndrome among women of reproductive age.
RESEARCH DESIGN AND METHODS—Participants were
1,399 women (39% black, aged 18–30 years) in the Coronary
Artery Risk Development in Young Adults (CARDIA) Study, an
ongoing multicenter, population-based, prospective observa-
tional cohort study conducted in the U.S. Women were nullipa-
rous and free of the metabolic syndrome at baseline (1985–1986)
and before subsequent pregnancies, and reexamined 7, 10, 15,
and/or 20 years after baseline. Incident metabolic syndrome case
participants were identiﬁed according to National Cholesterol
Education Program Adult Treatment Panel III (NCEP ATP III)
criteria. Complementary log-log models estimated relative haz-
ards of incident metabolic syndrome among time-dependent
lactation duration categories by gestational diabetes mellitus
(GDM) adjusted for age, race, study center, baseline covariates
(BMI, metabolic syndrome components, education, smoking,
physical activity), and time-dependent parity.
RESULTS—Among 704 parous women (620 non-GDM, 84
GDM), there were 120 incident metabolic syndrome case partic-
ipants in 9,993 person-years (overall incidence rate 12.0 per 1,000
person-years; 10.8 for non-GDM, 22.1 for GDM). Increased lacta-
tion duration was associated with lower crude metabolic syn-
drome incidence rates from 0–1 month through 9 months (P 
0.001). Fully adjusted relative hazards showed that risk reduc-
tions associated with longer lactation were stronger among GDM
(relative hazard range 0.14–0.56; P  0.03) than non-GDM groups
(relative hazard range 0.44–0.61; P  0.03).
CONCLUSIONS—Longer duration of lactation was associated
with lower incidence of the metabolic syndrome years after
weaning among women with a history of GDM and without GDM,
controlling for preconception measurements, BMI, and sociode-
mographic and lifestyle traits. Lactation may have persistent
favorable effects on women’s cardiometabolic health. Diabetes
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actation has favorable effects on cardiometabolic
risk factors in women with and without a history
of gestational diabetes mellitus (GDM), a strong
predictor of type 2 diabetes (1,2) and the meta-
bolic syndrome after pregnancy (3). In the general popu-
lation, lactating compared with nonlactating women
exhibit a less atherogenic lipid proﬁle (4) and lower blood
glucose and insulin concentrations (5). Consistent with
these ﬁndings, lactating women with recent GDM experi-
ence lower fasting plasma glucose and insulin levels,
higher plasma HDL cholesterol levels, and 50% lower
prevalence of type 2 diabetes at 12–16 weeks postpartum
(6,7).
Yet, few studies have investigated whether lactation’s
favorable effects on cardiometabolic risk factors persist
after weaning to protect women against future disease.
The only study, to our knowledge, to measure changes
from preconception to after weaning reported 6-mg/dl
higher average HDL cholesterol levels among women who
lactated for 3 months versus 3 months independent of
preconception plasma HDL cholesterol levels and weight
gain (8). Epidemiologic studies have reported weak to
modest protective associations between lactation and
disease risk in midlife to late life, including lower preva-
lence of the metabolic syndrome (9,10) or cardiovascular
risk factors (11) and lower incidence of myocardial infarc-
tion (12) and type 2 diabetes (13). Yet, evidence is lacking
that directly links risk factor changes that persist after
weaning to subsequent disease onset, because disease
status and lactation history were ascertained decades after
pregnancy, and preconception and/or postweaning risk
factor measurements were not available (9–13). Other
limitations include classiﬁcation of outcomes via self-
report only (11–13), and failure to account for mediating
or confounding effects of lifestyle habits during the repro-
ductive years. Lastly, lactation duration in relation to
disease risk has not been examined separately among
women with a history of GDM, with the exception of one
study reporting a null association with incident diabetes
(13).
To our knowledge, studies have never examined lacta-
tion and incidence of the metabolic syndrome, or variation
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prospectively examined whether increasing duration of
lactation was associated with lower incidence of the
metabolic syndrome during a 20-year period among
women of childbearing age. We examined incidence rates
for GDM and non-GDM pregnancies and controlled for
preconception risk factor levels, sociodemographics, and
follow-up behavioral attributes.
RESEARCH DESIGN AND METHODS
The Coronary Artery Risk Development in Young Adults (CARDIA) Study is a
multicenter, longitudinal, population-based, observational study designed to
describe the development of risk factors for coronary heart disease in young
black (52%) and white adults recruited from four geographic areas in the U.S.:
Birmingham, Alabama, Chicago, Illinois, Minneapolis, Minnesota, and Oak-
land, California. The study design, recruitment, methodology, and cohort
characteristics have been previously described (14,15). In 1985–1986, baseline
data were collected for 2,787 women aged 18–30 years. All metabolic
syndrome components were measured at exams in years 0, 7, 10, 15, and 20.
Retention rates were 81, 79, 74, and 72% of the surviving cohort (16,17).
Institutional review boards at each participating study center approved the
study. Written, informed consent was obtained from participants for all study
procedures.
Sample selection criteria. Of 2,787 women enrolled at baseline, we ex-
cluded 1,008 women who were parous at baseline; 18 women currently
pregnant or breastfeeding, pregnant within the past 3 months, or who reported
a previous hysterectomy; 4 women with type 1 diabetes; and 92 women who
met the National Cholesterol Education Program Adult Treatment Panel III
(NCEP ATP III) criteria for the metabolic syndrome at baseline (Fig. 1).
Further, we excluded 213 women missing covariates or with incomplete
information on all ﬁve components to ascertain the metabolic syndrome at
baseline and for at least one follow-up exam, 11 primiparas who delivered a
multifetal pregnancy during the ﬁrst follow-up interval, and 42 women missing
all lactation information. Biochemical measurements at exams (years 0, 7, 10,
15, and 20) from currently pregnant or lactating women were not used in the
analysis. Among the sample of 1,399 nulliparas who were free of the metabolic
syndrome at baseline, 695 women were classiﬁed as nulliparous during
follow-up (677 never gave birth, 9 developed the metabolic syndrome prior to
any births, and 9 had later multifetal births only). The data from 704 women
who subsequently delivered at least one singleton, live birth during the 20-year
period (1986–2006) were used to examine the association of lactation
duration and incidence of the metabolic syndrome. These 704 women were
more likely than the 695 who remained nulliparous to be married, were
slightly younger and thinner, were not using oral contraceptives, and had
lower diastolic blood pressure levels at baseline.
Data collection methods. Methodologies for data collection and venipunc-
ture are described elsewhere (14,15,18). Brieﬂy, women fasted prior to each
exam, and reported the number of hours since their last intake of food or
beverages prior to the blood sample drawn into a Vacutainer tube containing
EDTA. Procedures followed in the collection and storage of plasma samples,
laboratory quality-control procedures, and methodology for analysis of
plasma triglycerides (TGs), HDL cholesterol, LDL cholesterol, and total
cholesterol are described elsewhere (18,19). Serum glucose was measured at
year 0 using the hexokinase ultraviolet method by American Bio-Science
Laboratories (Van Nuys, CA) and at years 7, 10, 15, and 20 using hexokinase
coupled to glucose-6-phosphate dehydrogenase by Linco Research (St. Louis,
MO).
Blood pressure measurements. After an initial 5-min rest, blood pressure
was measured three times at 1-min intervals. At the baseline and year-7, -10,
and -15 follow-up exams, blood pressure was measured using the Hawksley
(Lancing, Sussex, U.K.) random-zero sphygmomanometer; the ﬁrst and ﬁfth
phase Korotkoff sounds were recorded (15). At the year-20 exam, blood
pressure was measured with an automated sphygmomanometer (Omron
HEM907XL oscillometer; Omron, Schaumburg, IL). The protocol speciﬁed the
appropriate cuff size (small, medium, large, extra large) based on the upper
arm circumference, which was measured by the blood pressure technician at
the midpoint between the acromion and the olecranon. Omron values were
recalibrated to corresponding random zero values based on a study of both
measurement techniques in 903 participants at year 20, as estimated random
zero systolic value  3.74  0.96  Omron systolic value, and estimated
random zero diastolic value  1.30  0.97  Omron diastolic value.
Anthropometric measurements. Certiﬁed technicians obtained anthropo-
metric measurements (weight, height, and waist circumference) at each exam
according to standardized protocol (20). Body weight was measured to the
nearest 0.2 kg using a calibrated balance beam scale in participants wearing
light clothing. Height (without shoes) was measured to the nearest 0.5 cm
using a vertical ruler, and waist circumference to the nearest 0.5 cm at the
minimal abdominal girth (21). BMI was computed as weight in kilograms
divided by squared height in meters.
Deﬁnition of the metabolic syndrome. Participants who developed the
metabolic syndrome (incident cases) were identiﬁed at follow-up exams
(years 7, 10, 15, and 20) using the NCEP ATP III criteria (22). The metabolic
syndrome was deﬁned as the presence of three of ﬁve characteristics: 1) waist
girth 88 cm, 2) fasting TG 150 mg/dl, 3) HDL cholesterol 50 mg/dl, 4)
systolic blood pressure 130 or diastolic blood pressure 85 mmHg or
treatment with antihypertensive medication, and 5) fasting glucose 100
mg/dl or treatment with diabetes medication. Incident metabolic syndrome
case participants were ascertained subsequent to births delivered since
baseline among women free of the metabolic syndrome before pregnancy, and
in the nonpregnant and nonlactating state at exams. Incident case participants
were censored from subsequent time intervals, and births that occurred
during those intervals were not included in the analysis.
Number of pregnancies and births. At each exam, women reported
whether they were currently pregnant or lactating, number of pregnancies
including abortions, miscarriages, and live or stillbirths since the previous
exam, along with length(s) of gestation, multifetal gestation, dates of deliv-
ery(ies), and diabetes during pregnancy. Interim births were deﬁned as
singleton pregnancies of longer than 20 weeks of gestation that were
conceived and delivered after baseline. We ascertained preexisting diabetes
before pregnancy as distinct from GDM pregnancy based on biochemical
(fasting and 2-h glucose levels) and medical history (1) data. We also validated
self-report of GDM among 165 women for whom laboratory data were
abstracted from medical records for 200 births between baseline and year 10.
Sensitivity for classiﬁcation by self-report as ever having GDM was 100% (20
of 20), and speciﬁcity was 92% (134 of 145).
We classiﬁed women into time-dependent interim birth groups during the
follow-up period based on the cumulative number of singleton births and by
GDM status: 0 births, one or more non-GDM births, or one or more GDM births
within four intervals extending from baseline through years 7, 10, 15, and 20.
Women transitioned from 0 births into one or more (1) non-GDM or GDM
birth groups within an interval, and group assignments remained for subse-
quent intervals, except when a GDM birth occurred after a non-GDM birth;
then non-GDM would transition into the GDM group. Once classiﬁed with
GDM, a woman remained in that category until the end of the follow-up
regardless of GDM status for subsequent births.
Time-dependent parity (continuous covariate) was deﬁned as the cumula-
tive number of births since baseline and was updated at each exam through
the end of follow-up.
Time-dependent lactation categories. Women reported the number of
months of lactation for each pregnancy by choosing one of the following
categories: none, 6 weeks, 6–11 weeks, 3–6 months, or 6 months. To
calculate the duration of lactation across all births, we assigned the midpoint
of the interval for each lactation category as follows: 21 days for 6 weeks, 66
days for 6–11 weeks, and 135 days for 3–6 months. For 6 months of
lactation, we assigned a value of 210 days as the upper limit. Duration of
lactation for each time interval was obtained by summing the number of days
of lactation across all births within an interval. Total cumulative duration of
lactation was updated for subsequent interval(s) by summing the duration for
all prior intervals.
Time-dependent lactation categories were designated within non-GDM and
GDM birth groups. Women were classiﬁed into one of four lactation groups for
each time interval: 0–1 month, 1–5 months, 6–9 months and 9 months,
representing the cumulative lactation duration for all births since baseline for
the interval. Within non-GDM and GDM groups, the referent group was 0–1
month.
Other baseline and follow-up covariates. Sociodemographic, medical, and
behavioral data (medication use, alcohol intake [ml/day], cigarette smoking,
education, marital status, oral contraceptive use, physical activity) were
collected at each exam using self- and interviewer-administered question-
naires. Baseline categorical variables were smoking (never, former, or cur-
rent), years of education (12 or fewer, 13–15, and 16 or more), marital status
(never married, widowed, divorced or separated, or married), and oral
contraceptive use (never, past, or current). Medication use, including insulin,
oral hypoglycemics, and antihypertensives, was self-reported. A positive
family history of diabetes was based on report of one or more ﬁrst-degree
relatives (father, mother, or siblings) with diabetes at the examinations in
years 0, 5, and 10.
We assessed daily physical activity at each examination using the inter-
viewer-administered CARDIA Physical Activity History (23) to calculate
physical activity scores (race-speciﬁc quartiles) that have correlated positively
with symptom-limited graded treadmill exercise test duration (24). Time-
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ing, oral contraceptive use, and parity groups for each follow-up time interval.
Statistical methods. Baseline and follow-up characteristics were described
for outcome groups, and for the main effect, duration of lactation groups, by
GDM status. We examined baseline characteristics: age, race, BMI, metabolic
syndrome components (fasting plasma TG, HDL cholesterol, glucose levels,
systolic and diastolic blood pressures, waist girth), diabetes, cigarette smok-
ing, education, marital status, oral contraceptive use, alcohol, physical activ-
ity, and dietary intake. Follow-up characteristics included parity, family
history of diabetes, and GDM status. 
2 tests were used to assess associations
with sociodemographic, medical history, study center, and behavioral cate-
gorical variables. t test statistics were used to assess the difference in
continuous variables by incident metabolic syndrome. Multiple linear regres-
sion methods (ANOVA) were used to assess baseline differences in continuous
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at baseline (1985-86)
-1,008 women, parous at baseline
1,008 women,
parous at baseline
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-92 women with the metabolic
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(1,273 total births)
695 women, nulliparous 
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later multifetal births)
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at baseline)
syndrome data
 before all births, and 9 women had
FIG. 1. Flow diagram for analytic sample selection: 704 women who were nulliparous, free of the metabolic syndrome, and aged 18–30 years at
baseline (1985–1986) who delivered at least one singleton live birth during the 20-year follow-up period.
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duration of lactation groups. Wilcoxon rank sum and Kruskal-Wallis one-way
tests were used to assess differences in alcohol intake and physical activity
scores (median and interquartile range) due to skewing in the distributions. P
values were obtained from two-sided tests (signiﬁcance 0.05). Physical
activity, weight gain, oral contraceptive use, parity, and smoking were
examined as time-dependent covariates.
Metabolic syndrome incident case participants for each interval were
categorized into time-dependent lactation categories and by GDM status
during 20-year follow-up. To describe the pattern of new case participants
over time, we calculated the cumulative incidence of metabolic syndrome
(n/N, %) within each time interval (0–7, 7–10, 10–15, and 15–20 years) by
dividing the number of incident case participants at the end of the interval by
the number of women at risk of the metabolic syndrome at the beginning of
the interval according to the lactation category and birth group assigned for
that speciﬁc time interval. Women may transition into interim birth groups and
longer lactation duration categories as parity and months of lactation increase
through the end of follow-up.
We estimated unadjusted incidence rates of the metabolic syndrome for
lactation groups by dividing the number of incident case participants of the
metabolic syndrome by the person-time for individuals observed during the
preceding intervals, then computed the exact 95% CIs. At each exam, women
reported the number of births and months of lactation since the previous
exam during follow-up. Person-time is contributed by each individual to a
speciﬁc lactation category and interim birth group for the entire time interval
during which they transitioned into a new category or birth group. During
follow-up, women may contribute person-time to multiple lactation catego-
ries, and potentially to both non-GDM and GDM birth groups depending on
whether non-GDM birth(s) preceded GDM birth(s) among successive inter-
vals. Women remain in their group assignments through subsequent intervals
unless additional births and/or months of lactation occur. For 23 births among
a total of 1,273, lactation duration was missing and women had no previous
births, so we assigned those births to the 0–1 month lactation category.
Because metabolic syndrome status was determined only at CARDIA
exams, the exact failure time for a woman without the metabolic syndrome at
a particular exam and identiﬁed with the metabolic syndrome at the subse-
quent exam is unknown. We accounted for interval-censored data using the
method of Prentice and Gloeckler (25) to provide point and interval estimates
of the relative hazard of metabolic syndrome associated with exposure. These
estimates were obtained in the context of a generalized linear model for binary
outcome with a complementary log-log link function. The hazard ratio for
incidence of metabolic syndrome was estimated for lactation categories within
GDM status groups at exams in years 7, 10, 15, and 20. Multivariable adjusted
models (SAS version 9.1; SAS Institute, Cary, NC) included race, study center,
time, baseline covariates (age, education, smoking), as well as the follow-up
covariate, time-dependent parity, to account for differences in number of births
across lactation categories (model 1). Next, we added other baseline covariates,
BMI and all metabolic syndrome components, to model 1. To form the fully
adjusted model, we then added baseline physical activity. Finally, we added
time-dependent physical activity and weight gain, separately, as potential medi-
ators of the lactation association by stepwise addition. Family history of diabetes
and time-dependent smoking and oral contraceptive use had little impact on the
results, and were not included in the fully adjusted model.
RESULTS
During 20 years, 704 participants without the metabolic
syndrome before pregnancies delivered one or more sin-
gleton births (620 non-GDM, 84 GDM), and 695 women
remained nulliparous. Among non-GDM and GDM groups,
respectively, 252 (40%) and 21 (25%) women delivered one
birth, 271 (44%) and 47 (56%) women delivered two births,
and 97 (16%) and 16 (19%) women delivered three or more
births during follow-up, for a total of 1,273 total births.
Among 704 parous women, there were 120 incident
metabolic syndrome case participants in 9,993 person-
years. The overall crude incidence rate was 12.0 case
participants per 1,000 person-years (95% CI 10.0–14.3).
Crude incidence rates were higher (P  0.002) among
women with GDM versus non-GDM pregnancies: 22.1 per
1,000 person-years (95% CI 14.1–33.0) and 10.8 per 1,000
person-years (95% CI 8.8–13.2), respectively. Among 695
nulliparas, there were 129 incident metabolic syndrome
TABLE 1
Baseline characteristics (1985–1986), family history of diabetes, GDM status, and lactation duration among incident metabolic
syndrome case participants and noncase participants (1986–2006)
Baseline characteristics
Incident metabolic syndrome
case participants (n  120)
Noncase participants
(n  584) P*
Race (black) 67 (55.8) 212 (36.3) 0.001
Education (high school or less) 41 (34.2) 148 (25.3) 0.06
Marital status (married) 22 (18.3) 99 (17.0) 0.64
Smoker (current) 27 (22.5) 125 (21.4) 0.90
Oral contraceptive use (current) 25 (20.8) 163 (27.9) 0.28
Family history of diabetes† 54 (45.0) 146 (25.0) 0.001
Type 2 diabetes 1 (0.8) 1 (0.2) 0.31
GDM status (ever)† 23 (19.2) 61 (10.4) 0.007
Age (years) 23.8  3.7 23.7  3.6 0.75
BMI (kg/m
2) 26.8  6.0 22.3  3.5 0.001
Waist girth (cm) 78.7  12.1 69.1  6.5 0.001
Fasting
Glucose (mg/dl) 82.1  7.8 79  7.1 0.001
HDL cholesterol (mg/dl) 53.8  13.1 58.2  12.2 0.001
TGs (mg/dl) 73.3  37.7 61.2  35.2 0.001
Systolic blood pressure (mmHg) 110.5  9.1 104.6  8.6 0.001
Diastolic blood pressure (mmHg) 68.5  9.6 65.3  8.7 0.001
Dietary intake (% kJ)
Fat 36.9  6.3 37.1  6.1 0.68
Saturated fat 13.9  3.0 13.8  3.0 0.83
Carbohydrate 47.4  7.4 46.9  7.4 0.50
Fiber (g)/1,000 kJ 0.54  0.28 0.57  0.28 0.29
Alcohol intake (ml/day)‡ 2.4 (9.6) 2.4 (9.7) 0.53
Physical activity score‡ 286.5 (281.0) 332.0 (339.5) 0.06
Lactation (months)†‡ 2.6 (7.0) 7.0 (9.3) 0.001
Data are n (%) or means  SD. 
2 test was used for categorical baseline characteristics; t test was used for continuous baseline
characteristics. *Two-sided P value. †Ascertained during the 20-year follow-up period. ‡Median (interquartile range), Wilcoxon rank sum test.
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11.1 per 1,000 person-years (95% CI 9.3–13.2).
Compared with noncase participants, incident meta-
bolic syndrome case participants (Table 1) differed in
baseline characteristics including higher BMI, waist girth,
fasting plasma glucose and TGs, and systolic and diastolic
blood pressures as well as lower HDL cholesterol levels
and physical activity scores. Incident metabolic syndrome
case participants were also more likely to be black, to
develop GDM, to have less education, to have a family
history of diabetes, or to have a shorter duration of
lactation.
Baseline characteristics differed among lactation cate-
gories (Table 2). Among the GDM group, lactation for 0–1
month compared with longer duration of lactation was
associated with black race, less education, smoking, fam-
ily history of diabetes, younger age, higher waist girth,
BMI, fasting plasma TGs, total dietary fat and saturated fat
intakes, and lower dietary ﬁber intake (g)/1,000 kJ. Lacta-
tion 9 months was associated with not smoking, older
age, and higher physical activity score. Differences in
baseline characteristics followed a similar pattern among
lactation categories for the non-GDM group.
Incident metabolic syndrome case participants in-
creased over time as the cohort aged (Table 3), with the
greatest increase between years 15 and 20 compared with
TABLE 2
Baseline characteristics (1985–1986) and family history of diabetes for lactation categories stratiﬁed by GDM status (1986–2006)
Characteristics
Women with non-GDM births, lactation categories
0–1 month 1–5 months 6–9 months 9 months P*
n 157 157 152 154
Race (black) 99 (63.1) 74 (47.1) 49 (32.2) 24 (15.6) 0.001
Education (HS) 73 (46.5) 44 (28.0) 31 (20.4) 23 (14.9) 0.001
Smoker (current) 42 (26.8) 40 (25.5) 22 (14.5) 20 (13.0) 0.001
Family history of diabetes 51 (32.5) 53 (33.8) 37 (24.3) 26 (16.9) 0.002
Age (years) 22.9  3.6 23.6  3.3 23.9  3.7 24.5  3.7 0.001
BMI (kg/m
2) 24.2  4.9 22.9  4.0 22.6  3.7 22.0  3.1 0.001
Waist girth (cm) 72.9  9.0 70.3  8.0 69.1  7.3 69.3  6.2 0.001
Systolic blood pressure (mmHg) 106.1  9.1 105.6  8.5 106.1  9.2 104.6  9.2 0.41
Diastolic blood pressure (mmHg) 65.5  8.7 65.4  9.6 66.2  8.8 65.9  8.6 0.87
Fasting
Glucose (mg/dl) 78.9  7.5 78.9  7.1 79.9  6.5 79.5  6.7 0.50
HDL cholesterol (mg/dl) 55.9  12.2 57.8  12.8 59.1  11.7 58.4  12.7 0.13
TGs (mg/dl) 66.7  33.0 58.7  23.4 59.0  26.8 65.0  54.2 0.11
Dietary intake (% kJ)
Total fat 37.4  6.5 37.9  6.3 37.0  5.2 35.4  6.2 0.01
Saturated fat 14.0  3.1 14.0  3.1 14.0  2.7 13.1  2.9 0.01
Carbohydrate 47.1  8.1 46.3  7.3 46.8  6.6 48.0  7.8 0.23
Fiber (g)/1,000 kJ 0.47  0.26 0.55  0.24 0.60  0.26 0.66  0.34 0.001
Alcohol intake (ml/day)† 0.0 (7.6) 2.4 (9.5) 2.4 (9.7) 4.8 (12.1) 0.07
Physical activity score† 258.0 (280.0) 320.0 (317.0) 334.0 (382.0) 402.0 (362.0) 0.001
Women with GDM births, lactation categories
0–1 month 1–5 months 6–9 months 9 months P*
n 22 17 17 28
Race (black) 16 (72.7) 7 (41.2) 4 (23.5) 6 (21.4) 0.001
Education (HS) 8 (36.4) 6 (35.3) 2 (11.8) 2 (7.1) 0.03
Smoker (current) 10 (45.5) 9 (52.9) 6 (35.3) 3 (10.7) 0.03
Family history of diabetes 11 (50.0) 3 (17.6) 6 (35.3) 13 (46.4) 0.16
Age (years) 22.8  4.0 22.4  3.7 24.2  3.9 24.9  3.6 0.10
BMI (kg/m
2) 27.0  8.3 23.5  4.5 23.9  4.7 22.6  4.1 0.05
Waist girth (cm) 79.5  18.7 70.8  7.8 72.1  9.1 70.5  8.2 0.05
Systolic blood pressure (mmHg) 108.4  8.0 102.6  7.7 103.3  8.6 107.6  10.4 0.10
Diastolic blood pressure (mmHg) 70.3  7.3 60.4  10.7 65.2  7.0 68.7  8.8 0.01
Fasting
Glucose (mg/dl) 80.0  8.7 78.8  10.8 81.8  9.1 82.9  9.2 0.48
HDL cholesterol (mg/dl) 52.7  13.1 53.3  12.7 56.9  15.4 56.9  11.7 0.59
TGs (mg/dl) 74.5  25.9 70.6  35.7 64.1  30.0 70.0  34.3 0.79
Dietary intake (% kJ)
Total fat 37.3  5.6 37.0  3.3 40.4  7.8 37.7  5.6 0.29
Saturated fat 14.4  2.8 14.0  1.9 15.3  4.5 13.8  3.0 0.44
Carbohydrate 47.4  6.7 46.3  5.4 43.8  8.8 46.2  6.9 0.46
Fiber (g)/1,000 kJ 0.41  0.16 0.48  0.20 0.50  0.22 0.62  0.23 0.01
Alcohol intake (ml/day)† 1.2 (7.6) 7.3 (18.4) 7.9 (15.2) 2.4 (8.6) 0.29
Physical activity score† 233.0 (297.0) 292.0 (153.0) 429.0 (334.0) 280.5 (309.0) 0.22
Data are n (%) or means  SD. 
2 test was used for categorical baseline characteristics; one-way ANOVA was used for continuous baseline
characteristics. *Two-sided P value. †Median (interquartile range), Kruskal-Wallis test.
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metabolic syndrome was highest for 0–1 month regardless
of GDM status.
Incident metabolic syndrome case participants were
more likely to develop new onset diabetes during follow-
up: 19 (16%) of metabolic syndrome case participants and
16 (3%) of noncase participants (P  0.001). Mean (SD)
years since last birth were slightly fewer for metabolic
syndrome case participants than noncase participants: 7.9
(5.0) and 9.2 (4.8), respectively (P  0.01).
Crude incidence rates (number of case participants per
1,000 person-years) were higher for GDM than non-GDM
groups across all lactation groups except for 9 months
(Fig. 2). The incidence rates (95% CI) decreased with
increasing duration of lactation: from 15.8 (11.3–21.5) to
9.2 (5.3–14.6) among the non-GDM group and from 49.4
(25.8–84.7) to 8.5 (1.8–24.8) among the GDM group.
Overall, there was a sixfold lower crude incidence rate of
the metabolic syndrome for 9 months versus 0–1 month
of lactation among the GDM group, and a twofold lower
incidence rate for the highest versus lowest duration of
lactation among the non-GDM group. Within race groups,
we examined crude incidence rates for 1 month versus
0–1 month of lactation, and found similar protective
associations, except for blacks in the non-GDM group (Fig.
3). Median duration of lactation was shorter for blacks
than whites (4.5 [interquartile range 4.8] vs. 7.0 months
[9.2]; P  0.001). Crude incidence rates for baseline BMI
groups (25, 25) were consistent with the race results
(data not shown), including no difference in metabolic
syndrome rates for 1 month and 0–1 month lactation
categories among overweight women in the non-GDM
group.
In multivariable models stratiﬁed by GDM status (Table
4), duration of lactation was inversely associated with the
relative hazards of incident metabolic syndrome, from
1–5 months to 9 months compared with 0–1 month,
with a stronger inverse association among GDM (relative
hazard 0.11–0.24) than non-GDM groups (relative hazard
0.41–0.49) in unadjusted models (all P  0.001). Adjust-
ment for race, time-dependent parity, study center, and
baseline covariates (age, education, smoking) attenuated
relative hazards modestly, but a signiﬁcant inverse associ-
ation remained for GDM and non-GDM groups. In fully
adjusted models, addition of baseline BMI, all metabolic
syndrome components, and physical activity enhanced the
graded inverse associations with longer lactation, remain-
ing statistically signiﬁcant for GDM and non-GDM groups
(all P  0.03). Addition of time-dependent physical activity
during follow-up as a potential mediator revealed a stron-
ger protective association among GDM (relative hazard
0.13–0.41; P  0.02) than non-GDM groups (0.51–0.67; P 
0.10), whereas addition of weight gain in a separate model
strengthened the association among women with GDM
(0.09–0.49; P  0.01).
DISCUSSION
Among women with and without GDM pregnancies, a
longer cumulative duration of lactation was strongly pro-
tective, even after controlling for parity and baseline
covariates, including components of the metabolic syn-
drome before pregnancy. For women with non-GDM preg-
nancies, there was a threshold effect with lactation 1
month conferring protection compared with 0–1 month.
Among women with GDM pregnancies, we found a strong,
graded inverse association of lactation with incidence of
the metabolic syndrome, those with longest lactation
TABLE 3
Cumulative incidence of the metabolic syndrome during follow-up intervals by GDM status and among duration of lactation
categories (1986–2006)
Duration of lactation Year 0–7 Year 7–10 Year 10–15 Year 15–20
Non-GDM births (all) 8/382 (2.1) 13/463 (2.8) 30/515 (5.8) 46/463 (9.9)
0–1 month 5/143 (3.5) 6/147 (4.1) 14/124 (11.3) 15/93 (16.1)
1–5 months 2/101 (2.0) 3/126 (2.4) 6/131 (4.6) 11/120 (9.2)
6–9 months 1/89 (1.1) 3/114 (2.6) 5/132 (3.8) 9/121 (7.4)
9 months 0/49 (0.0) 1/76 (1.3) 5/128 (3.9) 11/129 (8.5)
GDM births (all) 6/43 (14.0) 5/53 (9.4) 3/61 (4.9) 9/55 (16.4)
0–1 month 4/16 (25.0) 2/12 (16.7) 1/10 (10.0) 5/9 (55.6)
1–5 months 1/8 (12.5) 1/15 (6.7) 0/13 (0.0) 2/13 (15.4)
6–9 months 1/9 (11.1) 0/9 (0.0) 1/14 (7.1) 2/11 (18.2)
9 months 0/10 (0.0) 2/17 (11.8) 1/24 (4.2) 0/22 (0.0)
Data shown are number of incident case participants of metabolic syndrome/number of individuals at risk within the speciﬁc interval (%).
FIG. 2. Crude incidence rates (95% CIs) of the metabolic syndrome
during 20 years of follow-up for lactation categories by GDM status.
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syndrome. The associations remained after controlling for
mediators such as changes in physical activity or weight
gain during follow-up, with a stronger protective associa-
tion among the GDM group.
Associations were similar within race and BMI groups,
especially for women with a history of GDM. However,
black women had much shorter duration of lactation that
limited our ability to fully assess the association of ex-
tended duration of lactation with disease risk. Overweight
status was closely related to black race, and our sample
size was too small to fully assess the separate effects. We
did not observe signiﬁcant interactions by number of
singleton pregnancies because most women (84%) deliv-
ered only one or two pregnancies.
Epidemiologic studies examining lactation history and
prevalence of the metabolic syndrome or cardiovascular
disease (CVD) risk have not measured preconception risk
factor levels or stratiﬁed by GDM status. Cross-sectional
studies of primarily perimenopausal and postmenopausal
women reported that lactation 1 month (9) or any
lactation (10) was associated with 21–22% lower preva-
lence of the metabolic syndrome, and that lactation 12
months was associated with 9–20% lower prevalence of
CVD risk factors, but not incidence of CVD (11). In studies
of lactation and type 2 diabetes after GDM and non-GDM
pregnancies, glucose levels before pregnancy were not
measured (6,7,13). Longer lifetime lactation 4 months
was associated with a 25% lower incidence of type 2
diabetes among white women, but not those with a history
of GDM (13). In Latinas with previous GDM, ﬁndings on
lactation and future diabetes risk were inconclusive, and
duration was not assessed (26).
Our ﬁndings for women of reproductive age show a
much stronger protective association for 1 month of
lactation: lower incidence of the metabolic syndrome by
39–56% for non-GDM and by 44–86% for GDM groups.
Because our sample included only nulliparas at baseline
and preconception measurements of all metabolic syn-
drome components, we minimized confounding by preex-
isting conditions before pregnancy and lactation.
Our study’s unique strengths include prospective collec-
tion of “preconception” measurements of the metabolic
syndrome components to conﬁrm that women were free of
the metabolic syndrome before pregnancies, and stratiﬁ-
cation by GDM status. Metabolic syndrome components
were measured at 3- to 7-year intervals before and after
pregnancies over a 20-year period, thereby maintaining the
temporality of the exposure (pregnancy and lactation
duration) to new onset of metabolic syndrome. We also
modeled lactation as a time-dependent main effect and
controlled for multiple potential confounders including
age, time-dependent parity, secular trends, sociodemo-
graphics, and behavioral attributes. The validity of our
ﬁndings is enhanced by the population-based sample, high
cohort retention rate over 20 years of follow-up, and
measurement of all ﬁve metabolic syndrome components
at baseline for 100% of the sample and for three or more
follow-up visits for 72% of the sample. We also examined
associations separately for black and white race groups,
and found consistent associations.
Limitations include no data on lactation intensity, ascer-
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Person-yrs 2,527 6.426     243 797
FIG. 3. Crude incidence rates (95% CIs) of the metabolic syndrome during 20 years of follow-up for lactation categories by GDM status
(1986–2006) and race (black and white).
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conception and from delivery relative to CARDIA exams,
and few higher order births. Our GDM validation study
showed high sensitivity and speciﬁcity of GDM by self-
report, and nondifferential misclassiﬁcation would bias
our ﬁndings toward the null. Women who lactated may
have had healthier lifestyles than women who did not
lactate, but we accounted for these traits as well as weight
gain. Despite control for various behavioral and other
potential confounders, residual confounding is always
possible in observational studies.
One proposed mechanism through which lactation may
inﬂuence cardiometabolic health is through greater weight
loss. Although milk production increases maternal total
energy expenditure by 15–25% (27,28), evidence for
greater postpartum weight loss is equivocal (29). Prospec-
tive studies that measured maternal weights (not self-
reported) before or during early pregnancy have generally
reported lower postpartum weight retention at 1 year
postpartum (30), more rapid loss approaching pregravid
weight (31), or 1–2 kg greater weight losses within 3–6
months postpartum among lactating women (32). Yet,
weight change did not explain the protective association
between lactation and the metabolic syndrome in our
study.
Another possibility is that lactation affects body compo-
sition and regional fat distribution. Well-nourished lactat-
ing women lose about 2 kg in total fat mass by 6 months
postpartum based on magnetic resonance imaging (33) or
mass spectrometry (34) and tend to mobilize more fat
from the thigh than the trunk (33). In lactating American
women, skinfold thickness was reduced in the suprailiac
and subscapular regions, but increased in the triceps
region (35). Yet, studies that compared lactating versus
nonlactating women using dual-energy X-ray absorptiom-
etry found greater declines in total body fat mass within
3–6 months postpartum (36) but no differences in mobili-
zation of fat from leg, arm, and trunk regions (36,37). In 26
women with previous GDM, visceral fat mass via computed
tomography at 3 months postpartum did not differ by lacta-
tion status (38). Longitudinal studies are needed to examine
postpartum visceral fat changes in larger samples.
Acutely, lactogenesis has favorable effects on maternal
cardiometabolic blood proﬁles, but few studies have ad-
justed for BMI, or measured postweaning levels. Lactating
women had lower plasma TGs (39,40) and higher plasma
HDL cholesterol levels and HDL cholesterol/total choles-
terol ratios at 3–6 months postpartum unadjusted for BMI
(4,41,42). They also had elevations in respiratory quotient
and carbohydrate utilization consistent with preferential
use of glucose (28). Moreover, lactating versus nonlactat-
ing women exhibited greater insulin sensitivity among
GDM and non-GDM groups (5,38). In postweaning studies,
plasma HDL cholesterol levels were higher with longer
duration of lactation after accounting for preconception
levels and weight gain (8), but lactation was not associated
with plasma total cholesterol or other lipids (8,43).
In summary, longer duration of lactation was associated
with lower incidence of the metabolic syndrome years
after delivery and after weaning among women with
non-GDM as well as GDM pregnancies. Lifestyle behaviors
did not explain these associations. Lactation may amelio-
rate the increased risk of the metabolic syndrome associ-
ated with higher parity (30% per birth in non-GDM, 150%
for GDM) (3). By contrast, other studies have not demon-
strated clear beneﬁts of lactation on future health of
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evidence that lactation may have lasting favorable effects
on metabolic risk proﬁles among women with a history of
GDM who are most susceptible to developing metabolic
diseases, as well as women without GDM. Further
investigation is needed to elucidate the mechanisms
through which lactation may inﬂuence women’s cardio-
metabolic risk proﬁles, and whether lifestyle modiﬁcations,
including lactation duration, may affect development of cor-
onary heart disease and type 2 diabetes, particularly,
among high-risk groups such as women with a history of
GDM.
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